Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Bioelectric Dysregulation in Cancer Initiation, Promotion, and Progression

View through CrossRef
Cancer is primarily a disease of dysregulation – both at the genetic level and at the tissue organization level. One way that tissue organization is dysregulated is by changes in the bioelectric regulation of cell signaling pathways. At the basis of bioelectricity lies the cellular membrane potential or Vmem, an intrinsic property associated with any cell. The bioelectric state of cancer cells is different from that of healthy cells, causing a disruption in the cellular signaling pathways. This disruption or dysregulation affects all three processes of carcinogenesis – initiation, promotion, and progression. Another mechanism that facilitates the homeostasis of cell signaling pathways is the production of extracellular vesicles (EVs) by cells. EVs also play a role in carcinogenesis by mediating cellular communication within the tumor microenvironment (TME). Furthermore, the production and release of EVs is altered in cancer. To this end, the change in cell electrical state and in EV production are responsible for the bioelectric dysregulation which occurs during cancer. This paper reviews the bioelectric dysregulation associated with carcinogenesis, including the TME and metastasis. We also look at the major ion channels associated with cancer and current technologies and tools used to detect and manipulate bioelectric properties of cells.
Title: Bioelectric Dysregulation in Cancer Initiation, Promotion, and Progression
Description:
Cancer is primarily a disease of dysregulation – both at the genetic level and at the tissue organization level.
One way that tissue organization is dysregulated is by changes in the bioelectric regulation of cell signaling pathways.
At the basis of bioelectricity lies the cellular membrane potential or Vmem, an intrinsic property associated with any cell.
The bioelectric state of cancer cells is different from that of healthy cells, causing a disruption in the cellular signaling pathways.
This disruption or dysregulation affects all three processes of carcinogenesis – initiation, promotion, and progression.
Another mechanism that facilitates the homeostasis of cell signaling pathways is the production of extracellular vesicles (EVs) by cells.
EVs also play a role in carcinogenesis by mediating cellular communication within the tumor microenvironment (TME).
Furthermore, the production and release of EVs is altered in cancer.
To this end, the change in cell electrical state and in EV production are responsible for the bioelectric dysregulation which occurs during cancer.
This paper reviews the bioelectric dysregulation associated with carcinogenesis, including the TME and metastasis.
We also look at the major ion channels associated with cancer and current technologies and tools used to detect and manipulate bioelectric properties of cells.

Related Results

Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract Background: We have previously reported the tumor suppressor effect of Secreted protein acidic and rich in cysteine (SPARC) in ovarian cancer in vitro and i...
Abstract POSTER-BIOL-1352: Notch3 promotes anoikis resistance in ovarian cancer
Abstract POSTER-BIOL-1352: Notch3 promotes anoikis resistance in ovarian cancer
Abstract Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer. Recently, a number of genome-wide studies in ovarian cancer patient samples have post...
Abstract POSTER-BIOL-1314: Investigating fatty acid beta-oxidation in ovarian cancer cells
Abstract POSTER-BIOL-1314: Investigating fatty acid beta-oxidation in ovarian cancer cells
Abstract Purpose: To investigate the contribution of fatty acid beta-oxidation to the total energy budget of ovarian cancer cells. Experimental proced...
Abstract POSTER-TECH-1106: Rational design of molecularly targeted therapy for GAB2-driven ovarian cancers
Abstract POSTER-TECH-1106: Rational design of molecularly targeted therapy for GAB2-driven ovarian cancers
Abstract Studies of cancer genomes indicate that high-grade serous ovarian cancers, the most aggressive subtype accounting for over 70% of all ovarian cancer deaths,...
Abstract 2172: Dying tumor cells (tumor debris) stimulate the growth of 4T1 breast cancer tumor in female athymic nude mice
Abstract 2172: Dying tumor cells (tumor debris) stimulate the growth of 4T1 breast cancer tumor in female athymic nude mice
Abstract Current cancer therapies are based on chemotherapy and radiation. These therapeutic approaches can initially reduce the tumor mass or tumor burden by killin...
Cancer immunotherapy: potential involvement of mediators
Cancer immunotherapy: potential involvement of mediators
The description of a cell‐free soluble anti‐tumour factor by Carswell et al. in 1975 (Proc Natl Acad Sci USA, 72: 3666–3670) was followed by a long series of experimental and clini...
Regulation of regulatory T cells and tumor‐associated macrophages in gastric cancer tumor microenvironment
Regulation of regulatory T cells and tumor‐associated macrophages in gastric cancer tumor microenvironment
AbstractIntroductionDespite advancements in the methods for prevention and early diagnosis of gastric cancer (GC), GC continues to be the fifth in incidence among major cancers and...
Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells
Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells
Clinical application of icariin (ICA) is limited, despite its activity against cancer growth, because of the low solubility of ICA in an aqueous environment. Therefore, the present...

Back to Top